Intelligence

#GLP-1 #Market reporting #Novo Nordisk #Obesity #Scandinavia #Weight loss

What effect have weight loss drugs had on the Scandinavian economy?

In less than a decade GLP-1 receptor agonists have transformed the treatment of obesity and made Novo Nordisk Europe’s most valuable company. Diana Spencer explores the current impact and potential future for these drugs. Originally designed in Scandinavia as a maintenance therapy for type 2 diabetes, GLP-1 receptor agonists are… Read More

#Exclusive Content #Market Reports #Trends & Analysis

#2025 predictions #Diagnostics #Drug discovery

Diagnostics: Industry predictions for 2025

DDW’s Megan Thomas spoke with industry experts about their predictions for drug discovery opportunities in 2025. Previously, with a focus on technology, machine learning (ML) and artificial intelligence (AI), as well as neuroscience, cancer research and cell and gene therapy. Here, looking through a diagnostics lens.  Jackie… Read More

#Business & Investment #Exclusive Content #Trends & Analysis

Ageing concept
#Age-related diseases (ARDs) #Ageing #Start-ups

The start-up addressing ageing and disease

DDW Editor Reece Armstrong speaks to Dr Carina Kern, Chief Executive Officer and Chief Scientific Officer, and Serena Kern-Libera, Chief Operating Officer, at LinkGevity about the company’s approach to tackling age-related diseases. RA: Could you tell us about LinkGevity’s approach to developing broad-spectrum therapeutics in the field of ageing? … Read More

#Exclusive Content #Start-up Zone

#2025 predictions #Cell and gene therapy #Drug discovery

Cell and gene therapy: Industry predictions for 2025

DDW’s Megan Thomas spoke with industry experts about their predictions for drug discovery opportunities in 2025. Previously, with a focus on technology, machine learning (ML) and artificial intelligence (AI), as well as neuroscience and cancer research. Here, looking at cell and gene therapy. For the last few… Read More

#Business & Investment #Exclusive Content #Trends & Analysis

#2025 predictions #Cancer #Cancer research #Drug discovery

Cancer burden and research: Industry predictions for 2025

DDW’s Megan Thomas spoke with industry experts about their predictions for drug discovery opportunities in 2025. Previously, with a focus on technology, machine learning (ML) and artificial intelligence (AI), as well as neuroscience. Here, looking at cancer burden and research in the sector. Ahead of World Cancer Day… Read More

#Business & Investment #Cancer Research #Exclusive Content #Trends & Analysis

RNA strand
#Akribion Therapeutics #Oncology #RNA #Seed funding #Start-ups

€8m financing to pioneer RNA-guided cell depletion 

Akribion Therapeutics has exited stealth mode and completed a seed financing round, raising €8 million to accelerate the development of novel therapeutics.  The round was led by CARMA FUND and RV Invest, with investments from MP Beteiligungs, Hessen Kapital I, Bruker Invest and High-Tech Gründerfonds. … Read More

#Business & Investment #Cancer Research #News #Start-up Zone

#2025 predictions #Drug discovery #Neuroscience

Neuroscience: Industry predictions for 2025

DDW’s Megan Thomas spoke with industry experts about their predictions for drug discovery opportunities in 2025. Previously, this was with a focus on technology, machine learning (ML) and artificial intelligence (AI). Here, looking at the neuroscience sector. At the Society for Neuroscience’s annual meeting, Neuroscience 2024, both the… Read More

#Business & Investment #Exclusive Content #Trends & Analysis

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Laboratory data #Machine learning

Standardising data: Why do it and how?

Standardisation is critical to extracting the full potential of analytical data – in facilitating data-driven science and AI/ML-powered innovation. This whitepaper will help you: Review currently available standard formats Understand the pros and cons of open and proprietary formats Ensure data is adequately prepared for scientists and AI/ML applications… Read More

#Resources

#Fc-Fusion proteins #Manufacturing #Protein chemistry / Proteomics

Accelerating CMC Strategies for Fab and Fc-Fusion Protein Development

Download the whitepaper to learn more about: Comprehensive CMC Solutions: Explore integrated Chemistry, Manufacturing, and Controls (CMC) strategies tailored to the unique challenges of Fab and Fc-Fusion protein development. Overcoming Complexity: Learn how flexible approaches can streamline the development of complex protein formats, ensuring robust and scalable manufacturing processes. Accelerating Development… Read More

#Resources

#Artificial intelligence (AI) #Automated liquid handling #Automation / robotics #eBook #Lab automation

The digital lab: Making the best use of technology (including liquid handling) in the lab

This eBook, sponsored by Revvity, examines the increasing role of digital tools in drug discovery and how these innovations could impact the development of therapeutics in the future. Download this exclusive eBook to learn more about: How digital innovation is helping drugs and therapeutics to get to market faster The… Read More

#DDW eBooks #Intelligence

#Artificial intelligence (AI) #Automation / robotics

Ebook: The digital lab Making the best use of technology (including liquid handling) in the lab

‘The digital lab’ can mean different things to different people, but the term broadly covers three types of laboratory systems: data management, automation and robotics, and artificial intelligence (AI) and machine learning (ML). Labs are looking to the potential cost and time savings these technologies can bring in an increasingly… Read More

#DDW eBooks

#Automated liquid handling #Automation / robotics #Library screening #Next generation sequencing

Optimise your NGS workflows: 5-day path to sequencing

This Scientific Note explores: The benefits of vendor-qualified protocols, incl. reducing start-up process. The three levels of automated library preparation readiness. How fully vendor-qualified libraries enable sequencing in as few as five days. The importance of choosing providers with NGS expertise. Case studies comparing custom vs. vendor-qualified solutions deployment. Read More

#Resources

#Artificial intelligence (AI) #Automation / robotics #Lab automation #Market reporting #Survey

AI is the automation trend researchers are most excited about

When it comes to future developments in lab automation technology, the integration of artificial intelligence (AI) is the top area of anticipation for drug discovery labs.   This is one of the key findings of the DDW Research & Consultancy 2025 Research Report Purchasing in Drug Discovery… Read More

#Editor's Choice #News #Trends & Analysis

#2025 predictions #Artificial intelligence (AI) #Drug discovery #Lab technology #Machine learning

Tech, ML and AI: Industry predictions for 2025

DDW’s Megan Thomas spoke with industry experts about their predictions for drug discovery opportunities in 2025. Here, the focus is on technology, machine learning (ML) and artificial intelligence (AI). In a prediction piece written for Forbes, contributor Bernard Marr outlined five key technology trends for 2025 across multiple industries1. With… Read More

#Business & Investment #Exclusive Content #Trends & Analysis